197 related articles for article (PubMed ID: 34988073)
1. Current Research Progress of the Role of LncRNA LEF1-AS1 in a Variety of Tumors.
Zheng Q; Yu X; Zhang M; Zhang S; Guo W; He Y
Front Cell Dev Biol; 2021; 9():750084. PubMed ID: 34988073
[TBL] [Abstract][Full Text] [Related]
2. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
Gao J; Dai C; Yu X; Yin XB; Zhou F
Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
[TBL] [Abstract][Full Text] [Related]
3. CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis.
Cheng Y; Wu J; Qin B; Zou BC; Wang YH; Li Y
Biochem Biophys Res Commun; 2020 Jun; 526(3):678-684. PubMed ID: 32248974
[TBL] [Abstract][Full Text] [Related]
4. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
Dong H; Jian P; Yu M; Wang L
J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of lncRNA LEF1-AS1 inhibited the progression of oral squamous cell carcinoma (OSCC) via Hippo signaling pathway.
Zhang C; Bao C; Zhang X; Lin X; Pan D; Chen Y
Cancer Biol Ther; 2019; 20(9):1213-1222. PubMed ID: 30983488
[TBL] [Abstract][Full Text] [Related]
6. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors.
Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y
Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
8.
Wang J; Liu X; Yan C; Liu J; Wang S; Hong Y; Gu A; Zhao P
Onco Targets Ther; 2017; 10():4251-4260. PubMed ID: 28894380
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/β-catenin pathway.
He H; Qin M
Clin Exp Pharmacol Physiol; 2020 May; 47(5):886-891. PubMed ID: 31990064
[TBL] [Abstract][Full Text] [Related]
10. LEF1-AS1 is implicated in the malignant development of glioblastoma via sponging miR-543 to upregulate EN2.
Zeng S; Zhou C; Yang DH; Xu LS; Yang HJ; Xu MH; Wang H
Brain Res; 2020 Jun; 1736():146781. PubMed ID: 32184164
[TBL] [Abstract][Full Text] [Related]
11. LncRNA landscape analysis identified LncRNA LEF-AS1 as an oncogene that upregulates LEF1 and promotes survival in chronic lymphocytic leukemia.
Du X; Liu H; Yang C; Shi X; Cao L; Zhao X; Miao Y; Zhu H; Wang L; Xu W; Li J; Fan L
Leuk Res; 2021 Nov; 110():106706. PubMed ID: 34563944
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of long noncoding RNA LEF1-AS1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Zong MZ; Feng WT; Du N; Yu XJ; Yu WY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7929-7934. PubMed ID: 31599448
[TBL] [Abstract][Full Text] [Related]
13. LEF1-AS1, long non-coding RNA, inhibits proliferation in myeloid malignancy.
Congrains-Castillo A; Niemann FS; Santos Duarte AS; Olalla-Saad ST
J Cell Mol Med; 2019 Apr; 23(4):3021-3025. PubMed ID: 30770626
[TBL] [Abstract][Full Text] [Related]
14. lncRNA
Yang J; Lin X; Jiang W; Wu J; Lin L
DNA Cell Biol; 2019 Sep; 38(9):1013-1021. PubMed ID: 31386568
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA LEF1-AS1 silencing suppresses the initiation and development of prostate cancer by acting as a molecular sponge of miR-330-5p via LEF1 repression.
Liu DC; Song LL; Liang Q; Hao L; Zhang ZG; Han CH
J Cell Physiol; 2019 Aug; 234(8):12727-12744. PubMed ID: 30613973
[TBL] [Abstract][Full Text] [Related]
16. DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA.
Hu C; Liu K; Wang B; Xu W; Lin Y; Yuan C
Curr Pharm Des; 2021; 27(9):1211-1218. PubMed ID: 33121401
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LEF1-AS1 promotes metastasis of prostatic carcinoma via the Wnt/β-catenin pathway.
Li W; Yang G; Yang D; Li D; Sun Q
Cancer Cell Int; 2020 Nov; 20(1):543. PubMed ID: 33292271
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
19. LncRNA LEF1-AS1 promotes osteogenic differentiation of dental pulp stem cells via sponging miR-24-3p.
Wu Y; Lian K; Sun C
Mol Cell Biochem; 2020 Dec; 475(1-2):161-169. PubMed ID: 32780211
[TBL] [Abstract][Full Text] [Related]
20. Potential role of lncRNA LOXL1-AS1 in human cancer development: a narrative review.
Tang M; Rong Y; Liu S; Wu Z; Ma G; Li X; Cai H
Transl Cancer Res; 2024 Apr; 13(4):1997-2011. PubMed ID: 38737681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
